Search

Your search keyword '"O'Rourke, Robert A."' showing total 98 results

Search Constraints

Start Over You searched for: Author "O'Rourke, Robert A." Remove constraint Author: "O'Rourke, Robert A." Database ScienceDirect Remove constraint Database: ScienceDirect
98 results on '"O'Rourke, Robert A."'

Search Results

2. Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study

13. Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial)

14. Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial

19. Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial

20. Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)

21. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

23. ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

25. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons

26. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons

27. Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424

28. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on Cardiac Catheterization Laboratory Standards : A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents endorsed by the American Heart Association and the Diagnostic and Interventional Catheterization Committee of the Council on Clinical Cardiology of the AHA

31. The Evolving Pattern of Symptomatic Coronary Artery Disease in the United States and Canada: Baseline Characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial

32. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial

33. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive Dru G Evaluation (COURAGE) trial : Veterans Affairs Cooperative Studies Program no. 424

36. Contributors

37. HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL IS ASSOCIATED WITH RESIDUAL RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DESPITE OPTIMAL LEVELS OF LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL: A POST HOC ANALYSIS FROM THE COURAGE TRIAL

38. A NEW RISK PREDICTION TOOL TO ASSESS LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE (SIHD): THE “COURAGE RISK SCORE”

44. Guidelines for clinical use of cardiac radionuclide imaging: A report of the american college of cardiology/american heart association task force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on radionuclide imaging)—developed in collaboration with the american society of nuclear cardiology

45. ACC/AHA task force report special report: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: Report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on perioperative cardiovascular evaluation for noncardiac surgery)

48. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Clinical Intracardiac electrophysiologic and catheter ablation procedures), developed in collaboration with the North American Society of pacing and electrophysiology

Catalog

Books, media, physical & digital resources